A2 A Pharmaceuticals, Inc. Biomea Fusion, Inc. (BMEA) insider trading activity
A2 A Pharmaceuticals, Inc. is > 10% Shareholder of Biomea Fusion, Inc.. Currently has a direct ownership of 3.5 Million shares of BMEA, which is worth approximately $14.1 Million. The most recent transaction as insider was on Jun 01, 2023, when has been sold 50,000 shares (Common Stock) at a price of $34.56 per share, resulting in proceeds of $1,728,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.5M
0%
3M change
0%
12M change
Total Value Held
$14.1 Million
A2A Pharmaceuticals, Inc. Transaction History
API
A2 A Pharmaceuticals, Inc.
> 10% Shareholder
Chappaqua, NY